Clinical Trial Update: Bone Marrow Cells in Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating bone marrow cell therapy in patients with acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Bone marrow cell therapy (bone marrow-derived cell therapy)

Snippet

Sponsor: University of Oulu | Conditions: Acute Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED